scout
Opinion|Videos|September 11, 2024

First-Line ICI-Based Combinations for mRCC With Sarcomatoid Features

Renal cancer experts conclude their discussion by examining first-line immune checkpoint inhibitor-based combination therapies for metastatic renal cell carcinoma with sarcomatoid features, and offer their final insights on the current state and future directions of RCC treatment.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME